STIM
STIM
NASDAQ · Health Care

Neuronetics Inc

$2.15
-0.28 (-11.52%)
Financial Highlights (FY 2026)
Revenue
191.09M
Net Income
-49,961,449
Gross Margin
48.5%
Profit Margin
-26.2%
Rev Growth
+31.8%
D/E Ratio
2.94
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.5% 48.5% 47.9% 47.9%
Operating Margin -21.1% -19.0% 15.6% 15.2%
Profit Margin -26.2% -24.8% 14.5% 15.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 191.09M 145.03M 42.77M 40.23M
Gross Profit 92.64M 70.31M 20.50M 19.29M
Operating Income -40,282,234 -27,515,187 6.66M 6.13M
Net Income -49,961,449 -34,126,672 6.19M 6.19M
Gross Margin 48.5% 48.5% 47.9% 47.9%
Operating Margin -21.1% -19.0% 15.6% 15.2%
Profit Margin -26.2% -24.8% 14.5% 15.4%
Rev Growth +31.8% +31.8% +12.6% +7.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 70.93M 70.93M 7.26M 6.78M
Total Equity 24.12M 24.12M 78.62M 70.17M
D/E Ratio 2.94 2.94 0.09 0.10
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -35,834,010 -25,836,604 9.04M 8.20M
Free Cash Flow — — 4.11M 4.07M